Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Total-Long-Term-Assets" stands at 81.99 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.
As of the end of Merck & Company Inc's third quarter, the item "Total Long Term Assets" stands at 81.99 Billion USD. This represents an increase of 1.90 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 6.24 percent compared to the value the year prior.
The 1 year change in percent is 6.24.
The 3 year change in percent is 11.52.
The 5 year change in percent is 29.68.
The 10 year change in percent is 12.83.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Long Term Assets | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Long Term Assets | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Long Term Assets | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Long Term Assets | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Long Term Assets | 280,205,508,085.11 |